3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Seroma
1
Rectal Neoplasms
1
Psoriasis
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Parotid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Cisplatin
5
Gemcitabine
4
Oxaliplatin
2
Irinotecan
2
Fluorouracil
2
Capecitabine
2
Bevacizumab
2
zanidatamab
1
toripalimab
1
pembrolizumab
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
durvalumab
1
binimetinib
1
Trastuzumab
1
Pemetrexed
1
Nivolumab
1
Folfox protocol
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Actigraphy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Standard of Care
×
30 days
×
Clear all
No trials found.